Company / PP&E per Share
Lilly (Eli) PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$27.32
FY2025
5-year range
$9.60 / $27.32
FY2021-FY2025
Trend
+44.5%
vs FY2024
Sector context
#4 of 191
Health Care
What the data says
Among 191 Health Care companies, Lilly (Eli) is in the top 2% for pp&e per share. PP&E per Share has increased for 6 consecutive years, from $7.48 in FY2019 to $27.32 in FY2025.
Based on SEC 10-K filings.
27.32 in FY2025 with a 5-year CAGR of +26.6%. Top quartile in the Health Care sector.
Improved from $14.16 to $27.32 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- +34.9%
- 5-Year CAGR
- +26.6%
- 10-Year CAGR
- -
Sector benchmark
Top 2% in Health CareTop 2% of 191This company $27.32 Sector average $18.90
▼
+44.6% above sector average
Key checks
Key Insights
- Lilly (Eli)'s pp&e per share has grown for 6 consecutive years.
- In FY2025, pp&e per share increased 44.5% year-over-year.
- Ranks #4 out of 191 companies in the Health Care sector.
- Lowest pp&e per share in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.02 (distress zone, below 1.8 threshold)
- Strong profit margin: 31.0%
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 77.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $27.32 | +44.5% |
| FY2024 | $18.91 | +33.5% |
| FY2023 | $14.16 | +27.4% |
| FY2022 | $11.12 | +15.8% |
| FY2021 | $9.60 | +14.3% |
| FY2020 | $8.40 | +12.2% |
| FY2019 | $7.48 | -0.6% |
| FY2018 | $7.53 | -9.1% |
| FY2017 | $8.28 | +7.8% |
| FY2016 | $7.68 | +3.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026